VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+40.5%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$47M
AUM Growth
+$47M
(-92%)
Cap. Flow
-$548M
Cap. Flow
% of AUM
-1,166.74%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
310
New
6
Increased
35
Reduced
92
Closed
151
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$515K |
| 2 |
Franklin FTSE India ETF
FLIN
|
$355K |
| 3 |
Puma Biotechnology
PBYI
|
$276K |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$255K |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$238K |
Top Sells
| 1 |
MPLX
MPLX
|
$60.3M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
$58.3M |
| 3 |
Energy Transfer Partners
ET
|
$49.7M |
| 4 |
Enterprise Products Partners
EPD
|
$41.7M |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$30.5M |
Sector Composition
| 1 | Healthcare | 88.12% |
| 2 | Financials | 0.73% |
| 3 | Communication Services | 0.52% |
| 4 | Consumer Discretionary | 0.46% |
| 5 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
76
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $257K | 0.55% |
86,904
-8,913
| -9% | -$26.4K |
|
77
BioCryst Pharmaceuticals
BCRX
$1.74B
| $255K | 0.54% |
31,277
-4,023
| -11% | -$32.8K |
|
|
MYOK
78
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $253K | 0.54% |
4,859
-735
| -13% | -$38.3K |
|
|
DCPH
79
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $246K | 0.52% |
10,578
-1,195
| -10% | -$27.8K |
|
|
AKCA
80
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $242K | 0.51% |
8,527
-1,083
| -11% | -$30.7K |
|
|
TECX
81
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $239K | 0.51% |
904
-119
| -12% | -$31.5K |
|
|
ITCI
82
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $230K | 0.49% |
18,878
-2,735
| -13% | -$33.3K |
|
83
Xencor
XNCR
$594M
| $222K | 0.47% |
7,160
-1,069
| -13% | -$33.1K |
|
84
Esperion Therapeutics
ESPR
$490M
| $220K | 0.47% |
5,483
-796
| -13% | -$31.9K |
|
|
ADAP
85
Adaptimmune Therapeutics
ADAP
$13.9M
| $218K | 0.46% |
50,655
-7,568
| -13% | -$32.6K |
|
86
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $212K | 0.45% |
11,763
-1,773
| -13% | -$32K |
|
87
Wave Life Sciences
WVE
$1.27B
| $209K | 0.44% |
5,373
-613
| -10% | -$23.8K |
|
88
ProQR Therapeutics
PRQR
$256M
| $207K | 0.44% |
14,925
-1,757
| -11% | -$24.4K |
|
89
Neuronetics
STIM
$208M
| $206K | 0.44% |
13,535
-1,737
| -11% | -$26.4K |
|
90
Inovio Pharmaceuticals
INO
$144M
| $197K | 0.42% |
4,412
-621
| -12% | -$27.7K |
|
91
CytomX Therapeutics
CTMX
$350M
| $194K | 0.41% |
18,085
-2,330
| -11% | -$25K |
|
92
Crinetics Pharmaceuticals
CRNX
$3.26B
| $181K | 0.39% |
7,934
-1,100
| -12% | -$25.1K |
|
|
ALLK
93
DELISTED
Allakos
ALLK
| $180K | 0.38% |
4,437
-577
| -12% | -$23.4K |
|
94
Karyopharm Therapeutics
KPTI
$61.4M
| $160K | 0.34% |
1,826
-222
| -11% | -$19.5K |
|
|
GTHX
95
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $144K | 0.31% |
8,654
-1,300
| -13% | -$21.6K |
|
|
AMRS
96
DELISTED
Amyris Inc.
AMRS
| $137K | 0.29% |
65,658
-9,636
| -13% | -$20.1K |
|
|
IMGN
97
DELISTED
Immunogen Inc
IMGN
| $136K | 0.29% |
50,045
-6,826
| -12% | -$18.6K |
|
|
UBX
98
DELISTED
Unity Biotechnology
UBX
| $134K | 0.29% |
1,653
-246
| -13% | -$19.9K |
|
99
Alibaba
BABA
$325B
| $94K | 0.2% |
516
-68
| -12% | -$12.4K |
|
100
HDFC Bank
HDB
$181B
| $92K | 0.2% |
1,596
+320
| +25% | +$18.4K |
|